Literature DB >> 30276356

Mitigating lumen-apposing metal stent dislodgment and allowing safe, single-stage EUS-directed transgastric ERCP.

Shayan Irani1, Julian Yang2, Mouen A Khashab2.   

Abstract

Entities:  

Keywords:  EDGE, EUS-directed transgastric ERCP; LAMS, lumen-apposing metal stent

Year:  2018        PMID: 30276356      PMCID: PMC6162347          DOI: 10.1016/j.vgie.2018.07.008

Source DB:  PubMed          Journal:  VideoGIE        ISSN: 2468-4481


× No keyword cloud information.
Until recently, patients with Roux-en-Y gastric bypass had the options of enteroscopy-assisted or surgery-assisted ERCP. However, the use of a lumen-apposing metal stent (LAMS) with EUS to create a transgastric fistula allows for ERCP with a duodenoscope (EUS-directed transgastric ERCP [EDGE]). However, dislodgement of the LAMS with advancement of the endoscope can result in a perforation, leading some providers to do this in 2 stages: LAMS placement followed by fistula maturation (7-14 days) and subsequent ERCP. To avoid this more expensive 2-step approach, and in cases in which waiting is not an option, we describe 5 cases in which an over-the-scope clip (OTSC) or endostitch was used to secure the LAMS, allowing a single-stage EDGE (Video 1, available online at www.VideoGIE.org).

Cases and endoscopic methods

Patient 1

A 41-year-old man with a 200-cm combined Roux-en-Y bypass and afferent limb length presented with gallstone pancreatitis and a retained common bile duct stone (Fig. 1). A 15-mm cautery-enhanced LAMS was used for the EDGE (Fig. 2). This was secured to the gastric pouch with a single 11/6t OTSC (Fig. 3). After balloon dilation of the LAMS, ERCP was performed to remove multiple black pigmented stones successfully. The patient returned 2 weeks later to have the LAMS removed using argon plasma coagulation to cut the OTSC (Fig. 4). Spontaneous transgastric fistula closure was allowed and was confirmed by an upper-GI series 4 weeks later (Fig. 5).
Figure 1

CT scan demonstrating pancreatitis and a distal common bile duct stone in Patient 1.

Figure 2

Use of 15-mm cautery-enhanced lumen-apposing metal stent to create a gastrogastric fistula in Patient 1.

Figure 3

Lumen-apposing metal stent secured to the gastric pouch with an 11/6t over-the-scope clip in Patient 1.

Figure 4

Use of argon plasma coagulation to cut and remove the over-the-scope clip securing the lumen-apposing metal stent in Patient 1.

Figure 5

Upper-GI series confirming closure of gastrogastric fistula 4 weeks after removal of lumen-apposing metal stent in Patient 1.

CT scan demonstrating pancreatitis and a distal common bile duct stone in Patient 1. Use of 15-mm cautery-enhanced lumen-apposing metal stent to create a gastrogastric fistula in Patient 1. Lumen-apposing metal stent secured to the gastric pouch with an 11/6t over-the-scope clip in Patient 1. Use of argon plasma coagulation to cut and remove the over-the-scope clip securing the lumen-apposing metal stent in Patient 1. Upper-GI series confirming closure of gastrogastric fistula 4 weeks after removal of lumen-apposing metal stent in Patient 1.

Patient 2

A 48-year-old woman with a 180-cm combined Roux-en-Y bypass and afferent limb length was admitted with pain and suspected choledocholithiasis. She underwent successful EDGE with a 15-mm cautery-enhanced LAMS. This was secured with 2 sutures to the gastric pouch (Fig. 6). A biliary sphincterotomy with removal of sludge was successfully performed. Four weeks later the LAMS was removed, allowing spontaneous fistula closure, which was confirmed by an upper-GI series 6 weeks later.
Figure 6

Lumen-apposing metal stent secured with 2 sutures to the gastric pouch in Patient 2.

Lumen-apposing metal stent secured with 2 sutures to the gastric pouch in Patient 2.

Results

Five patients (3 women, 2 men) with a mean age of 52 years (range, 32-71 years) underwent single-stage EDGE from June 2015 to August 2017. The indications for ERCP were choledocholithiasis in 3 patients and pancreatitis in 2 patients. EDGE was performed rather than enteroscopy-assisted ERCP in 4 patients because the length of the bypassed limb was very long (>180 cm), and pancreas divisum with relapsing pancreatitis was present in 1 patient. The LAMS was secured with an OTSC in 1 patient and sutured in 4 patients. All 5 patients underwent successful ERCP with a standard duodenoscope without LAMS dislodgement or adverse events (Tables 1 and 2). Although OTSC placement was faster (3 minutes vs 12 minutes to suture), advancement of the scope through the OTSC-secured LAMS and removal of the OTSC was technically more difficult, which is why after the first case of using the OTSC, a switch was made to suturing.
Table 1

Preprocedural and procedural data on patients undergoing EUS-directed transgastric ERCP with a 15 mm lumen-apposing metal stent (n = 5)

Patient numberAge/genderIndicationReason for antegrade approachSize and type of LAMSType of fistulaLAMS secured withERCP successful without LAMS dislodgement
171/FCholedocholithiasisVery long bypassed limb15 mm, coldGGStitchYes
241/MGallstone pancreatitisVery long bypassed limb15 mm, hotGGOTSCYes
348/FCholedocholithiasisVery long bypassed limb15 mm, hotGGStitchYes
432/FRelapsing pancreatitisPancreas divisum and failed DBE ERCP15 mm, hotGGStitchYes
569/MCholedocholithiasisVery long bypassed limb15 mm, hotGGStitchYes

DBE, Double-balloon enteroscopy; GG, gastrogastric fistula; LAMS, lumen-apposing metal stent; OTSC, over-the-scope clip.

Table 2

Postprocedural data on patients undergoing EUS-directed transgastric ERCP with a 15-mm lumen-apposing metal stent (n = 5)

Patient numberHospital stay after procedure (days)Adverse eventsLAMS dwell time in TG fistula (days)Confirmation of spontaneous TG fistula closureFollow-up since placement (days)
11No42UGI 49 days502
21No14UGI 30 days286
31No28UGI 40 days282
41No30UGI 38 days245
51No90NA90
Mean141281

NA, Not applicable; LAMS, lumen-apposing metal stent; TG, transgastric, UGI, upper-GI series.

Died of unrelated causes before being able to return for LAMS removal.

Preprocedural and procedural data on patients undergoing EUS-directed transgastric ERCP with a 15 mm lumen-apposing metal stent (n = 5) DBE, Double-balloon enteroscopy; GG, gastrogastric fistula; LAMS, lumen-apposing metal stent; OTSC, over-the-scope clip. Postprocedural data on patients undergoing EUS-directed transgastric ERCP with a 15-mm lumen-apposing metal stent (n = 5) NA, Not applicable; LAMS, lumen-apposing metal stent; TG, transgastric, UGI, upper-GI series. Died of unrelated causes before being able to return for LAMS removal. The mean LAMS dwell time was 41 days (range, 14-90 days). All patients were allowed to undergo spontaneous fistula closure, which was confirmed by upper-GI series in 30 to 50 days, with a mean follow-up time of 281 days (range, 90-502 days).

Conclusions

A safe, single-stage EDGE can be performed in Roux-en-Y gastric bypass patients without LAMS dislodgement by securing the stent to the gastric pouch with an OTSC or endoscopic stitch. Other options include the use of a pediatric duodenoscope through a 15-mm LAMS or a standard duodenoscope through a 20-mm LAMS. Comparative studies would be useful.

Disclosure

Dr Irani is a consultant for Boston Scientific and Gore Medical. Dr Khashab is a consultant for Boston Scientific, Olympus, and Medtronic and is on the medical advisory boards of Boston Scientific and Olympus. The other author disclosed no financial relationships relevant to this publication.
  2 in total

Review 1.  Endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y anatomy.

Authors:  Tercio L Lopes; C Mel Wilcox
Journal:  Gastroenterol Clin North Am       Date:  2010-03       Impact factor: 3.806

2.  Endoscopic ultrasound-guided creation of a transgastric fistula for the management of hepatobiliary disease in patients with Roux-en-Y gastric bypass.

Authors:  Saowanee Ngamruengphong; Jose Nieto; Rastislav Kunda; Vivek Kumbhari; Yen-I Chen; Majidah Bukhari; Mohamad Hassan El Zein; Renata P Bueno; Gulara Hajiyeva; Amr Ismail; Yamile Haito Chavez; Mouen A Khashab
Journal:  Endoscopy       Date:  2017-04-10       Impact factor: 10.093

  2 in total
  7 in total

1.  Single-Session Endoscopic Ultrasound-Directed Transgastric ERCP ("EDGE") in a Bariatric Patient with Pancreatic Mass and Biliary Obstruction.

Authors:  Petr Vanek; Shawn Mallery; Martin L Freeman; Guru Trikudanathan
Journal:  Obes Surg       Date:  2020-07-17       Impact factor: 4.129

2.  Endoscopic ultrasound-directed transgastric ERCP (EDGE): a systematic review describing the outcomes, adverse events, and knowledge gaps.

Authors:  Shaurya Prakash; B Joseph Elmunzer; Erin M Forster; Gregory A Cote; Robert A Moran
Journal:  Endoscopy       Date:  2021-03-08       Impact factor: 9.776

3.  Shortened-Interval Dual-Session EDGE Reduces the Risk of LAMS Dislodgement While Facilitating Timely ERCP.

Authors:  Matthew R Krafft; Wei Fang; John Y Nasr
Journal:  Dig Dis Sci       Date:  2020-08-20       Impact factor: 3.487

4.  An adverse event of EUS-directed transgastric ERCP: stent-in-stent technique to bridge the peritoneal gap.

Authors:  Anna Duloy; Hazem Hammad; Raj J Shah
Journal:  VideoGIE       Date:  2019-09-06

5.  EDGE in Roux-en-Y gastric bypass: How does it compare to laparoscopy-assisted and balloon enteroscopy ERCP: a systematic review and meta-analysis.

Authors:  Banreet Singh Dhindsa; Amaninder Dhaliwal; Babu P Mohan; Harmeet Singh Mashiana; Mohit Girotra; Shailender Singh; Gordon Ohning; Ishfaq Bhat; Douglas G Adler
Journal:  Endosc Int Open       Date:  2020-01-22

Review 6.  EUS-guided biliary drainage for postsurgical anatomy.

Authors:  Manol Jovani; Yervant Ichkhanian; Kia Vosoughi; Mouen A Khashab
Journal:  Endosc Ultrasound       Date:  2019-11-28       Impact factor: 5.628

Review 7.  Futuristic Developments and Applications in Endoluminal Stenting.

Authors:  Joel Ferreira-Silva; Renato Medas; Mohit Girotra; Monique Barakat; James H Tabibian; Eduardo Rodrigues-Pinto
Journal:  Gastroenterol Res Pract       Date:  2022-01-11       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.